Overview

Study of OZURDEX® in the Treatment of Diabetic Macular Oedema (DME) in Australia - The AUSSIEDEX Study

Status:
Completed
Trial end date:
2018-10-22
Target enrollment:
Participant gender:
Summary
This prospective study will assess Ozurdex in the treatment of Diabetic Macular Oedema in clinical practice.
Details
Lead Sponsor:
Allergan
Treatments:
BB 1101
Dexamethasone
Dexamethasone 21-phosphate
Dexamethasone acetate